Drug Shortage Report for MYLAN-SERTRALINE

Last updated on 2018-03-02 History
Report ID 5979
Drug Identification Number 02242520
Brand name MYLAN-SERTRALINE
Common or Proper name SERTRALINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SERTRALINE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-01
Actual start date
Estimated end date Unknown
Actual end date 2018-03-01
Shortage status Resolved
Updated date 2018-03-02
Company comments Discontinued in ID 20295
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2018-03-02 English Compare
v17 2018-03-01 French Compare
v16 2018-03-01 English Compare
v15 2017-12-04 French Compare
v14 2017-12-04 English Compare
v13 2017-10-24 French Compare
v12 2017-10-24 English Compare
v11 2017-10-19 French Compare
v10 2017-10-19 English Compare
v9 2017-10-19 English Compare
v8 2017-05-05 French Compare
v7 2017-05-05 English Compare
v6 2017-05-05 English Compare
v5 2017-04-13 French Compare
v4 2017-04-13 French Compare
v3 2017-04-13 English Compare
v2 2017-04-07 French Compare
v1 2017-04-07 English Compare

Showing 1 to 18 of 18